4//SEC Filing
Yu Yong 4
Accession 0001209191-23-058954
CIK 0001231457other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:15 PM ET
Size
7.1 KB
Accession
0001209191-23-058954
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
VP, Clinical Trial Operations
Transactions
- Sale
Common Stock
2023-12-15$14.18/sh−5,803$82,265→ 0 total - Sale
Common Stock
2023-12-15$12.94/sh−26,732$345,915→ 5,803 total
Footnotes (2)
- [F1]The weighted average sale price for the transaction reported was $12.9401, and the range of prices were between $12.69 and $13.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]The weighted average sale price for the transaction reported was $14.1763, and the range of prices were between $13.80 and $14.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
GENELUX Corp
CIK 0001231457
Entity typeother
Related Parties
1- filerCIK 0001937482
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:15 PM ET
- Size
- 7.1 KB